Over 30 million psychedelic users in the United States
Teri Suzanne Krebs, Pål-ørjan Johansen
F1000Research March 28, 2013 DOI: 10.12688/f1000research.2-98.v1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 57,873 |
| Population | US individuals aged 12 years and older |
| Keywords | Open peer review Plant biology Physiology Gerontology |
| Citations | 125 |
| Key findings | In 2010, approximately 32 million US residents had used psychedelics in their lifetime, with the highest prevalence among people aged 30 to 34. |
Abstract
We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females).
Citations in the library
Cited by 100
- Predicting Responses to Psychedelics: A Prospective Study Frontiers in Pharmacology November 2, 2018
- Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology December 25, 2017
- Psychedelics and Mental Health: A Population Study PLoS One August 19, 2013
- Psychedelics not linked to mental health problems or suicidal behavior: A population study Journal of Psychopharmacology March 1, 2015
- Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects Neuropsychopharmacology November 16, 2019
and 95 more in the library
Cites 4
- Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids TemaNord May 19, 2009
- Hallucinogens. Pharmacology & Therapeutics February 1, 2004
- A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Drug and Alcohol Dependence June 1, 2013
- Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron February 1, 2007